To validate the biological involvement of CCNYm and CCNYc in lung cancer progression, H1299-CCNY KD cells overexpressing EGFP as well as CCNYm and CCNYc were injected into mice via the tail vein. The gene discussed is CCNY; the disease is lung carcinoma.